Embracing Comprehensive Restructuring for a New Biopharmaceutical Era Continuing the Development of MGC Pharma’s Innovative Drug Portfolio LONDON, Feb. 13, 2024 /PRNewswire/ — MGC Pharmaceuticals Ltd (LSE: MXC), (OTC: MGCLF), (ASX: MXC) Rebrands as Argent BioPharma in Strategic…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.